Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry

Abstract Introduction Scientific evidence of the effectiveness of the tumor necrosis factor inhibitor adalimumab (ADA) in pediatric patients with non-infectious non-anterior uveitis is still limited. The aim of this study is to investigate the therapeutic role of ADA in a cohort of pediatric patient...

Full description

Bibliographic Details
Main Authors: Antonio Vitale, Francesca Della Casa, Silvana Guerriero, Gaafar Ragab, Angela Mauro, Valeria Caggiano, Marco Cattalini, Emanuela Del Giudice, Rossella Favale, Carla Gaggiano, Irene Bellicini, Maria Pia Paroli, Mohamed Tharwat Hegazy, Jurgen Sota, Abdurrahman Tufan, Alberto Balistreri, Ibrahim Almaghlouth, Francesco La Torre, Ewa Więsik-Szewczyk, Maria Tarsia, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Bruno Frediani, Gian Marco Tosi, Alex Fonollosa, José Hernández-Rodríguez, Rana Hussein Amin, Giuseppe Lopalco, Donato Rigante, Luca Cantarini, Claudia Fabiani
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-05-01
Series:Ophthalmology and Therapy
Subjects:
Anti-TNF
Autoinflammatory diseases
Clinical management
Ocular involvement
Personalized medicine
Rare diseases
Online Access:https://doi.org/10.1007/s40123-023-00712-1

Internet

https://doi.org/10.1007/s40123-023-00712-1

Similar Items